Framingham 10-Year CVD Risk Calculator

What the Framingham General CVD Risk Profile measures

The Framingham General CVD Risk Profile, published by D'Agostino and colleagues in 2008 in the journal Circulation, estimates the 10-year absolute risk of a first general cardiovascular disease event. Unlike earlier Framingham scores that focused narrowly on coronary heart disease (heart attack and coronary death), this General CVD profile is broader, it includes coronary death, myocardial infarction, coronary insufficiency, angina, ischemic and hemorrhagic stroke, transient ischemic attack, peripheral arterial disease, and heart failure. This makes it one of the most comprehensive single-score cardiovascular risk estimates available.

How the formula works

The model uses Cox proportional hazards regression with sex-specific coefficients. The key insight is that age, cholesterol, HDL, and systolic blood pressure are log-transformed before being multiplied by their coefficients, this captures the multiplicative effect of these risk factors. The formula computes a risk score, then converts it to a 10-year probability using the baseline survival function S0 and the mean risk score for the population. The result is a single percentage representing the probability of experiencing any general CVD event within 10 years.

Key coefficients for men

For men, the baseline survival S0 is 0.88936 and the mean risk score is 23.9802. The strongest predictor is log-transformed age (β = 3.06117), followed by log-transformed systolic blood pressure (β ≈ 1.93-2.00 depending on treatment status). HDL cholesterol is protective (β = −0.93), meaning higher HDL lowers risk. Smoking (β = 0.65) and diabetes (β = 0.57) each independently raise risk.

Key coefficients for women

For women, S0 is 0.95012 and the mean is 26.1931. The coefficients are generally similar in pattern but differ in magnitude, notably, systolic blood pressure has a larger coefficient for women (β ≈ 2.76-2.82), reflecting the stronger impact of hypertension in women. Diabetes also has a larger coefficient in women (β = 0.69 vs 0.57 for men).

Interpretation and clinical use

Risk below 10% is considered low, lifestyle optimization is the primary intervention. Risk of 10-20% is moderate, consider statin therapy, especially if LDL is elevated or other risk-enhancing factors are present. Risk above 20% is high, statin therapy is generally recommended, along with aggressive BP control and lifestyle change. The ACC/AHA 2018 cholesterol guidelines use the Pooled Cohort Equations (a similar but race-specific model) as the primary tool for statin decisions, but the Framingham General CVD profile remains widely used in clinical practice and research.

Limitations

The Framingham cohort is predominantly white and U.S.-based, which may overestimate or underestimate risk in other populations. The model does not incorporate family history, coronary calcium score, lipoprotein(a), or hs-CRP, all of which can refine risk. It is valid only for adults aged 30-74 without established cardiovascular disease. For secondary prevention (patients who already have CVD), the calculator does not apply, these patients are automatically high-risk and need aggressive management.